Press Releases Royalty Pharma plc

Stocks

RPRX

GB00BMVP7Y09

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:10:47 2026-06-18 am EDT			5-day change	1st Jan Change
51.44 ^USD	-4.22%		-6.95%	+33.15%

Jun. 09	Royalty Pharma plc Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 04:00 PM
Jun. 09	GSK buys cancer drug developer Nuvalent for USD10.6 billion	AN

Press Releases

Jun. 04	Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference	GL
May. 13	Royalty Pharma : Q1 2026 Financial Results Call Transcript	PU
May. 07	Royalty Pharma to present at upcoming investor conferences	GL
May. 06	Royalty Pharma : Q1 2026 Financial Results Presentation	PU
May. 06	Royalty Pharma : Q1 2026 Press Release	PU
May. 06	Royalty Pharma: Q1 Earnings Snapshot	AQ
May. 06	Royalty Pharma reports first quarter 2026 results	GL
Apr. 21	Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation	GL
Apr. 17	Royalty Pharma Declares Second Quarter 2026 Dividend	GL
Apr. 15	Royalty Pharma : Q1 2026 Pre-Quarterly Results Communication	PU
Apr. 15	Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026	GL
Apr. 14	Royalty Pharma : 2025 Corporate Responsibility Report pdf	PU
Mar. 30	Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases	GL
Mar. 23	Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence	GL
Mar. 17	Royalty Pharma Announces Expansion of Leadership Team	GL
Mar. 13	Royalty Pharma : TD Cowen Conference Transcript	PU
Mar. 02	Royalty Pharma : Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma’s Global Platform	PU
Mar. 02	Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform	GL
Mar. 02	Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform	AQ
Mar. 02	Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing	GL
Feb. 26	Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference	GL
Feb. 17	Royalty Pharma : Q4 2025 Financial Results Call Transcript	PU
Feb. 11	Royalty Pharma : Q4 2025 Financial Results Presentation	PU
Feb. 11	Royalty Pharma : Q4 2025 Financial Results	PU
Feb. 11	Royalty Pharma : Q4 2025 Financial Results	PU